Modification of Sample Size in Group Sequential Clinical Trials (Q4666658): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Created a new Item
 
Normalize DOI.
 
(5 intermediate revisions by 5 users not shown)
Property / DOI
 
Property / DOI: 10.1111/j.0006-341X.1999.00853.x / rank
Normal rank
 
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / Wikidata QID
 
Property / Wikidata QID: Q47213272 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance / rank
 
Normal rank
Property / cites work
 
Property / cites work: Discrete Sequential Boundaries for Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Stochastically curtailed tests in long–term clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designed Extension of Studies Based on Conditional Power / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1111/j.0006-341x.1999.00853.x / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2088238660 / rank
 
Normal rank
Property / DOI
 
Property / DOI: 10.1111/J.0006-341X.1999.00853.X / rank
 
Normal rank
links / mardi / namelinks / mardi / name
 

Latest revision as of 15:00, 30 December 2024

scientific article; zbMATH DE number 2155936
Language Label Description Also known as
English
Modification of Sample Size in Group Sequential Clinical Trials
scientific article; zbMATH DE number 2155936

    Statements

    Modification of Sample Size in Group Sequential Clinical Trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    13 April 2005
    0 references
    interim analysis
    0 references
    power
    0 references
    sample size
    0 references
    type I error
    0 references

    Identifiers